Charles Schwab Investment Management Inc Insmed Inc Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Insmed Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,546,607 shares of INSM stock, worth $116 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,546,607
Previous 1,444,266 7.09%
Holding current value
$116 Million
Previous $105 Million 1.28%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$66.29 - $76.63 $6.78 Million - $7.84 Million
102,341 Added 7.09%
1,546,607 $107 Million
Q3 2024

Nov 12, 2024
BUY
$62.0 - $79.01 $8.54 Million - $10.9 Million
137,670 Added 10.54%
1,444,266 $105 Million
Q2 2024

Aug 12, 2024
BUY
$22.0 - $69.71 $3.96 Million - $12.5 Million
179,829 Added 15.96%
1,306,596 $87.5 Million
Q1 2024

May 08, 2024
SELL
$25.72 - $29.94 $42,926 - $49,969
-1,669 Reduced 0.15%
1,126,767 $30.6 Million
Q4 2023

Feb 06, 2024
BUY
$23.42 - $31.74 $670,491 - $908,684
28,629 Added 2.6%
1,128,436 $35 Million
Q3 2023

Nov 08, 2023
BUY
$19.86 - $26.93 $1.76 Million - $2.39 Million
88,589 Added 8.76%
1,099,807 $27.8 Million
Q2 2023

Aug 09, 2023
BUY
$16.44 - $21.1 $84,698 - $108,707
5,152 Added 0.51%
1,011,218 $21.3 Million
Q1 2023

May 11, 2023
SELL
$16.26 - $21.73 $6,357 - $8,496
-391 Reduced 0.04%
1,006,066 $17.2 Million
Q4 2022

Feb 13, 2023
BUY
$16.98 - $23.15 $2.31 Million - $3.15 Million
136,230 Added 15.65%
1,006,457 $20.1 Million
Q3 2022

Nov 14, 2022
BUY
$20.88 - $28.21 $408,538 - $551,956
19,566 Added 2.3%
870,227 $18.7 Million
Q2 2022

Aug 15, 2022
SELL
$17.07 - $25.71 $154,517 - $232,726
-9,052 Reduced 1.05%
850,661 $16.8 Million
Q1 2022

May 13, 2022
BUY
$20.42 - $28.13 $207,038 - $285,210
10,139 Added 1.19%
859,713 $20.2 Million
Q4 2021

Feb 11, 2022
BUY
$25.89 - $33.45 $533,877 - $689,772
20,621 Added 2.49%
849,574 $23.1 Million
Q3 2021

Nov 16, 2021
BUY
$22.46 - $29.47 $722,201 - $947,607
32,155 Added 4.04%
828,953 $22.8 Million
Q2 2021

Aug 16, 2021
BUY
$24.17 - $36.01 $1.55 Million - $2.31 Million
64,281 Added 8.78%
796,798 $22.7 Million
Q1 2021

May 17, 2021
SELL
$32.28 - $44.3 $355,047 - $487,255
-10,999 Reduced 1.48%
732,517 $25 Million
Q4 2020

Feb 16, 2021
BUY
$31.45 - $40.54 $1.41 Million - $1.82 Million
44,952 Added 6.43%
743,516 $24.8 Million
Q3 2020

Nov 13, 2020
BUY
$26.0 - $34.5 $701,402 - $930,706
26,977 Added 4.02%
698,564 $22.5 Million
Q2 2020

Aug 14, 2020
BUY
$14.11 - $29.42 $1.61 Million - $3.36 Million
114,371 Added 20.53%
671,587 $18.5 Million
Q1 2020

May 15, 2020
BUY
$13.63 - $33.98 $144,777 - $360,935
10,622 Added 1.94%
557,216 $8.93 Million
Q4 2019

Feb 07, 2020
BUY
$16.12 - $24.98 $182,929 - $283,473
11,348 Added 2.12%
546,594 $13.1 Million
Q3 2019

Nov 08, 2019
BUY
$15.49 - $25.78 $699,745 - $1.16 Million
45,174 Added 9.22%
535,246 $9.44 Million
Q2 2019

Aug 09, 2019
BUY
$23.0 - $32.19 $1.09 Million - $1.52 Million
47,353 Added 10.7%
490,072 $12.5 Million
Q1 2019

May 14, 2019
BUY
$13.91 - $31.15 $325,299 - $728,473
23,386 Added 5.58%
442,719 $12.9 Million
Q4 2018

Feb 14, 2019
BUY
$11.6 - $18.7 $18,490 - $29,807
1,594 Added 0.38%
419,333 $5.5 Million
Q3 2018

Nov 13, 2018
BUY
$18.95 - $28.08 $333,690 - $494,460
17,609 Added 4.4%
417,739 $8.45 Million
Q2 2018

Aug 08, 2018
BUY
$20.0 - $29.72 $373,720 - $555,347
18,686 Added 4.9%
400,130 $9.46 Million
Q1 2018

May 07, 2018
BUY
$21.69 - $32.99 $429,071 - $652,608
19,782 Added 5.47%
381,444 $8.59 Million
Q4 2017

Jan 17, 2018
BUY
$26.43 - $31.78 $366,425 - $440,597
13,864 Added 3.99%
361,662 $11.3 Million
Q3 2017

Nov 13, 2017
BUY
$11.61 - $31.21 $4.04 Million - $10.9 Million
347,798
347,798 $10.9 Million

Others Institutions Holding INSM

# of Institutions
498
Shares Held
189M
Call Options Held
3.21M
Put Options Held
2.72M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.1B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email